CN Stock MarketDetailed Quotes

Teyi Pharmaceutical Group (002728)

Watchlist
  • 10.72
  • +0.14+1.32%
Not Open Mar 25 15:00 CST
5.50BMarket Cap67.42P/E (TTM)

Teyi Pharmaceutical Group (002728) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Chinese patent medicine494.51M53.49%
Chemical preparation357.59M38.68%
Chemical raw material65.42M7.08%
Chemical products and others7.01M0.76%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry908.06M98.22%
Pharmaceutical commerce9.46M1.02%
Chemical products and others7.01M0.76%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
South China486.68M52.64%
East China157.95M17.08%
Northeast China75.93M8.21%
Southwest62.04M6.71%
North China52.97M5.73%
Central China52.12M5.64%
Northwest35.96M3.89%
Overseas869.17K0.09%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On March 25 Eastern Time, according to Press TV, Iran's official media, reports on Wednesday indicated that Iran firmly rejected a ceasefire Show More